LOS ANGELES--(BUSINESS WIRE)--Lifeforce, the first comprehensive, clinically integrated health optimization platform, today announced the close of its $12 million Series A funding round, co-led by M13 and Peterson Ventures. The oversubscribed round also includes participation by Ridgeline Ventures, Rosecliff Ventures, and Seaside Ventures. In a fragmented healthcare market, Lifeforce operates as the trusted partner for people seeking to take proactive control of their health by bringing together the biomarker data, clinical expertise, and validated interventions needed to optimize health and longevity.
“No one should have to settle for feeling average as they age. People want a convenient solution for functioning at their best, and the peace of mind that they are on the right track to live a long and healthy life,” said Dugal Bain-Kim, co-founder and CEO of Lifeforce. “Eighty-five percent of Lifeforce members report improved quality of life within the first three months of being on a Lifeforce program. We analyze key biomarkers to find out where people are sub-optimal and close those gaps so they can feel stronger, think clearer, and live longer.”
The company was incubated by M13’s in-house venture studio, Launchpad, which has built multiple businesses in the health and wellness space. It is additionally backed by some of the most influential figures in health and human performance including renowned author, life and business strategist, and Lifeforce Co-Founder Tony Robbins; technologist, physician, engineer, and Lifeforce Co-Founder Dr. Peter Diamandis; and professional tennis legend Serena Williams.
Lifeforce: The Future of Preventative Care
Traditional paradigms are shifting as consumers grow increasingly dissatisfied with a confusing and expensive healthcare system, as well as a health and wellness industry that often lacks scientific rigor. A recent study from McKinsey also shows 88% of consumers prioritize personalization as much or more than three years ago.
Through a convenient telehealth driven model, Lifeforce lowers cost, reduces friction, and makes personalized health optimization more accessible. Members receive regular in-home diagnostic blood tests from registered phlebotomists covering the 40-plus biomarkers most important to physical, cognitive, sexual, and psychological performance. Results are then interpreted by a team of highly trained medical doctors to create a personalized program of scientifically validated lifestyle adjustments, nutraceuticals, and hormone and peptide therapies customized to each member's biology and goals. Unlike most other longevity platforms, members also have direct ongoing access to specialized clinicians and health coaches and are re-tested every three months to track progress and refine programs accordingly.
Lifeforce’s model was developed under the guidance of an expert Advisory Board including Dr. Mark Hyman, Head of Strategy and Innovation of the Cleveland Clinic Center for Functional Medicine; Dr. Fatima Cody Stanford, Weight Management Expert and Associate professor at Harvard Medical School; Dr. Rudy Tanzi, Harvard Medical School Vice-Chair of Neurology and Massachusetts General Hospital Director and Dr. Kathryn Rexrode, Chief of the Division of Women’s Health in the Department of Medicine at Brigham and Women’s Hospital (BWH) and a Professor of Medicine at Harvard Medical School.
"I've spent 35 years helping people unlock their potential. Over that time I've learned that if you're not in the driver's seat of your health, you're not going to be your most powerful self," said Tony Robbins, Co-Founder, Lifeforce. “So much more is possible in life when you decide to be proactive and assert yourself as the CEO of your own health. We launched Lifeforce to make it easier for people to do that.”
The latest round of financing enables Lifeforce to accelerate growth, expand its offering, and cement its position as the world’s leading health optimization platform. The company is also working on data tools that will allow it to further improve the efficacy of its personalized programs, while lowering cost.
“Lifeforce is poised to have a transformative impact, not just redefining the health optimization category but the very way we think about what’s possible as we age,” said Courtney Reum, Lifeforce Board Chairman and Co-founder at M13. “Demand for personalized proactive healthcare is growing exponentially and the team’s collective expertise in health, technology, and business uniquely positions Lifeforce to meet this demand.”
“Lifeforce is a comprehensive, convenient platform that takes the guesswork out of balancing hormones, nutrients, metabolism, and organ health so we not only live longer but live better,” said Mark Hyman, MD, Lifeforce Advisor.
At a fraction of the cost of other offerings, a Lifeforce membership starts at $349 for an initial baseline assessment and $129 per month for membership thereafter.
For more information and to start your Lifeforce journey, visit mylifeforce.com.
Lifeforce empowers adults to take control of their health, by combining the data, tools, and expertise to think clearer, feel stronger, and ultimately, live longer. On a mission to improve quality of life for 5M people by 2030, Lifeforce simplifies and consolidates members’ health ecosystems into the first clinically integrated health optimization platform. Through convenient at-home diagnostics, access to expert functional medicine physicians and certified health coaches, and data-driven highly personalized care plans, Lifeforce redefines the way we approach preventative healthcare and aging. For more information, visit www.mylifeforce.com, and follow along via social /golifeforce.